Although the Myc protein sequence remains unaltered in most cancers, exceptions occur in the above-cited lymphomas, where over half contain recurrent and often multiple Myc point mutations, which are generally confined to the N-terminal transcriptional regulatory domain (TRD). The gene discussed is MYC; the disease is cancer.